The Pediatric Interventional Cardiology Market is forecasted to reach US$ 3,917.21 Million through 2030, according to the report. Pediatric Interventional Cardiology is a medical field that gives a less invasive solution for congenital coronary heart defects. Its goal is to reduce the need for open-coronary heart surgical operation and optimize general results. In other phrases, Pediatric Interventional Cardiology is a minimally invasive remedy alternative to surgery for a few heart problems. However, it's worth noting that maximum interventional cardiology methods are nevertheless taken into consideration invasive as they require much equipment to go into the frame or perform open surgical procedures.
The pediatric interventional cardiology market proportion is expanding swiftly, driven by the rising prevalence of cardiac disorders in children and technological advancements. The demand for these devices is likewise pushed by the growing prevalence of congenital cardiac illnesses and authorities’ initiatives on this filed. Furthermore, the market benefits from the growing recognition and popularity of less invasive procedures.
Furthermore, public and private companies' growing occurrence of coronary heart diseases and initiatives are expected to contribute to the market's thriving. Public and personal groups worldwide are making more investment in pediatric interventional cardiology to provide perfect care of coronary heart patients of all ages, mainly pediatric patients. This trend is predicted to retain in upcoming years, further riding the market increase.
Extensive research and development efforts, growing consumer healthcare spending, and investments from governmental and non-governmental organizations to enhance healthcare infrastructure are key drivers propelling the market. Additionally, substantial technological developments in cardiology contribute to the marketplace's increase. The pediatric interventional cardiology market companies are expected to benefit from the growing attention on developing novel devices. The occurrence of congenital heart conditions is growing, leading to a surge in demand for new cardiology devices. Therefore, market players are that specialize in growing and launching progressive devices.
In May 2022, Royal Philips introduced the global release of EchoNavigator 4.0, a complicated picture-guided therapies approach to deal with structural heart sickness (SHD). EchoNavigator complements that manipulate of stay fusion imaging for users of Philips' EPIQ CVXi interventional cardiology ultrasound device within the company Image Guided Therapy System. The Pediatric Interventional Cardiology Market is valued at US$ 2,543.93 Million in 2023.
This groundbreaking medical procedure utilizes catheters for the implantation or replacement of heart valves, offering a less invasive option compared to conventional surgical interventions. The rising incidence of cardiovascular diseases and the preference for minimally invasive procedures contribute to the increasing demand for catheter-based valve implantation. Progress in medical technology, combined with positive results and shortened recovery periods, establishes this method as a key contributor in the changing realm of interventional cardiology. With growing awareness and adoption, the market is poised to experience substantial financial benefits.
The pediatric interventional cardiology market proportion is expanding swiftly, driven by the rising prevalence of cardiac disorders in children and technological advancements. The demand for these devices is likewise pushed by the growing prevalence of congenital cardiac illnesses and authorities’ initiatives on this filed. Furthermore, the market benefits from the growing recognition and popularity of less invasive procedures.
Pediatric Interventional Cardiology market is projected to obtain a CAGR of 6.36% from 2024 to 2030 globally
Congenital heart defects (CHD), affecting about 1% of newborns or 40,000 births annually in the United States, according to CDC's January 2022, embody numerous types, with ventricular septal disorders (VSD) being the most common. The growing prevalence of CHD, in particular mild types, is riding the adoption of pediatric interventional cardiology devices. The growing awareness of Pediatric Interventional Cardiology and surged efforts for early coronary heart disease detection contribute to the device adoption. Public and private companies globally make investments significantly in pediatric interventional cardiology for comprehensive care, further propelling market growth in the forecast period.Furthermore, public and private companies' growing occurrence of coronary heart diseases and initiatives are expected to contribute to the market's thriving. Public and personal groups worldwide are making more investment in pediatric interventional cardiology to provide perfect care of coronary heart patients of all ages, mainly pediatric patients. This trend is predicted to retain in upcoming years, further riding the market increase.
Extensive research and development efforts, growing consumer healthcare spending, and investments from governmental and non-governmental organizations to enhance healthcare infrastructure are key drivers propelling the market. Additionally, substantial technological developments in cardiology contribute to the marketplace's increase. The pediatric interventional cardiology market companies are expected to benefit from the growing attention on developing novel devices. The occurrence of congenital heart conditions is growing, leading to a surge in demand for new cardiology devices. Therefore, market players are that specialize in growing and launching progressive devices.
In May 2022, Royal Philips introduced the global release of EchoNavigator 4.0, a complicated picture-guided therapies approach to deal with structural heart sickness (SHD). EchoNavigator complements that manipulate of stay fusion imaging for users of Philips' EPIQ CVXi interventional cardiology ultrasound device within the company Image Guided Therapy System. The Pediatric Interventional Cardiology Market is valued at US$ 2,543.93 Million in 2023.
Stents are expected to hold a substantial market share over the upcoming years
By Device Type, the Pediatric Interventional Cardiology Market is segmented into Transcatheter Heart Valves, atherectomy, Catheters, Closure Devices, Balloons, Stents, and Others. The Stents segment is anticipated to dominate the global pediatric interventional cardiology market throughout the forecast period. This projection is grounded in the increasing prevalence of congenital heart defects in pediatric patients, necessitating effective and minimally invasive interventions. Stents are pivotal in addressing such cardiac issues, offering a reliable solution for pediatric interventional cardiology procedures. Their versatility and adaptability contribute to their prominence, providing physicians with a valuable tool to address various pediatric cardiovascular conditions. This trend indicates stent-based interventions' growing importance and efficacy in pediatric cardiac care.Catheter-Based Valve Implantation is poised for considerable revenue growth in the foreseeable future
By Procedure, the Pediatric Interventional Cardiology Market is divided into catheter ablation, congenital heart defect correction, angioplasty, coronary thrombosis, and others. Catheter-Based Valve Implantation is poised to achieve substantial revenue growth in the coming years.This groundbreaking medical procedure utilizes catheters for the implantation or replacement of heart valves, offering a less invasive option compared to conventional surgical interventions. The rising incidence of cardiovascular diseases and the preference for minimally invasive procedures contribute to the increasing demand for catheter-based valve implantation. Progress in medical technology, combined with positive results and shortened recovery periods, establishes this method as a key contributor in the changing realm of interventional cardiology. With growing awareness and adoption, the market is poised to experience substantial financial benefits.
Hospital segment will lead the Pediatric Interventional Cardiology market in 2023 and beyond
By End Use, the Pediatric Interventional Cardiology Market is classified into Hospitals, Ambulatory Surgical Centers, and Others. In 2023 and beyond, the hospital segment is poised to lead the Pediatric Interventional Cardiology market. Hospitals are primary centers for pediatric cardiac interventions, equipped with specialized facilities and skilled healthcare professionals. The increasing prevalence of congenital heart diseases and the demand for advanced cardiac care contribute to the dominance of hospitals in this sector. The comprehensive infrastructure of hospitals, coupled with their ability to provide diverse pediatric cardiology services, positions them as key contributors to the growth and development of the Pediatric Interventional Cardiology market.China will capture the majority of the market share
By Countries, Pediatric Interventional Cardiology Market is split into North America (United States, Mexico & Canada), Asia (Australia, China, India, Japan), South America (Brazil & Argentina), Middle East & Africa (Israel, Saudi Arabia, South Africa), Europe (Spain, France, Belgium, Germany, Italy, Netherland, Switzerland Turkey, and United Kingdom) and Rest of World. Over the past decade, there have been notable changes in the cardiology field in China. Specifically, interventional cardiology has made impressive strides in managing coronary artery disease. Unfortunately, this disease has become increasingly prevalent in a country that was once known for its low incidence of the condition. Contributing factors include rising affluence, adopting Western dietary habits and lifestyles, and widespread smoking. Looking ahead, China is poised for significant growth in this area, thanks to untapped opportunities, a large patient population, improved healthcare facilities, government support, medical tourism, and increased manufacturing investment.Key Players
Abbott Laboratories, Boston Scientific Corporation, General Electric, Medtronic, Siemens AG, and Cardinal Health Inc. are prominent pediatric interventional cardiology market players.Device Type - Market has been covered from 6 viewpoints:
- Transcatheter Heart Valves
- Atherectomy Devices
- Catheters
- Closure Devices
- Balloons
- Stents
- Others
Procedure - Market has been covered from 5 viewpoints:
- Catheter-based Valve I mplation
- Congenital Heart Defect Correction
- Angioplasty
- Coronary Thrombectomy
- Others
End Use - Market has been covered from 3 viewpoints:
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinic
Country - This report covers the 22 countries Pediatric Interventional Cardiology Market
North America
- United States
- Canada
- Mexico
Europe
- Belgium
- France
- Germany
- Italy
- Spain
- Switzerland
- United Kingdom
- Turkey
- Netherland
- South America
- Brazil
- Argentina
Asia Pacific
- Australia
- China
- India
- Japan
Middle East & Africa
- Saudi-Arabia
- Israel
- South Africa
Rest of the World
Company Insights:
- Overview
- Recent Development
- Financial Insights
Companies Covered:
- Abbott Laboratories
- Boston Scientific Corporation
- General Electric
- Medtronic
- Siemens AG
- Cardinal Health Inc.
Table of Contents
1. Introduction2. Research & Methodology3. Executive Summary5. Global Pediatric Interventional Cardiology Market
4. Market Dynamics
6. Market Share Analysis - Global Pediatric Interventional Cardiology Market
7. Device Type - Global Pediatric Interventional Cardiology Market
8. Procedure - Global Pediatric Interventional Cardiology Market
9. End Use - Global Pediatric Interventional Cardiology Market
10. Country - Global Pediatric Interventional Cardiology Market
11. Porter’s Five Analysis- Global Pediatric Interventional Cardiology Market
12. SWOT Analysis - Global Pediatric Interventional Cardiology Market
13. Key Players - Pediatric Interventional Cardiology Market
List of Figures
List of Tables
Companies Mentioned
- Abbott Laboratories
- Boston Scientific Corporation
- General Electric
- Medtronic
- Siemens AG
- Cardinal Health Inc.
Methodology
In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.
Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.
Primary Research
The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:
- Validates and improves the data quality and strengthens research proceeds
- Further develop the analyst team’s market understanding and expertise
- Supplies authentic information about market size, share, growth, and forecast
The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:
- Chief executives and VPs of leading corporations specific to the industry
- Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
- Key opinion leaders (KOLs)
Secondary Research
The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Patent and regulatory databases for understanding of technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic new articles, webcasts, and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | January 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 2.54 Billion |
| Forecasted Market Value ( USD | $ 3.91 Billion |
| Compound Annual Growth Rate | 6.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 6 |
